TrialsgrambetaRCTs are beautiful

NICE-SUGAR

2009

Intensive versus Conventional Glucose Control in Critically Ill Patients

In 6,104 ICU patients, intensive glucose control (81–108 mg/dL) increased 90-day mortality versus conventional (<180 mg/dL), with much more severe hypoglycaemia.

Result

Efficacy: 90-day all-cause mortalityOR 1.14 · P = 0.02

Below 1 favours intensive glucose control (81–108 mg/dL), above 1 favours conventional (<180 mg/dL).

Event rates
Absolute difference
2.6 points
NNH
39

Absolute difference and NNH are derived from the event rates.

Also reported: Severe hypoglycaemia 6.8% vs 0.5%.

Original publication
Subtopic
Glucose control
Design
International RCT
Relevance
Practice-defining: a trial the field needs to know.
Source
NICE-SUGAR Study Investigators. N Engl J Med. 2009;360(13):1283-1297.doi 10.1056/NEJMoa0810625

Discussion & critique

Buried tight glucose control; modern targets are <180 mg/dL (Surviving Sepsis 144–180).